Medical research

Alzheimer's study links cholesterol and toxic protein clusters

Cholesterol tremendously increases the toxicity of a peptide implicated in Alzheimer's progression, according to research by scientists in the Department of Biochemistry and Biophysics in Texas A&M's College of Agriculture ...

Medications

30 years on, are we winning the fight against Alzheimer's?

UC San Francisco experts say that we have reached a pivotal point in Alzheimer's disease research, 30 years after the first pharmaceutical came to market. On Jan. 6, 2023, the Food and Drug Administration is expected to give ...

Neuroscience

Targeting tau, the other protein behind Alzheimer's disease

In November, researchers reported the drug lecanemab slowed the progression of Alzheimer's disease. The effect was modest, but it has generated tremendous excitement because it was the first time a drug had been shown to ...

Medical research

Tackling the ethical considerations of dementia research

When Emily Largent worked as an ICU nurse at UCLA, she didn't shy away from the difficult cases. It wasn't necessarily the medical procedures themselves that were challenging; caring for patients after organ transplants or ...

page 6 from 40